Back
Palisade Bio Vs. Fate Therapeutics Industry Stock Comparison
Buy
53
PALI
Palisade Bio
Last Price:
7.65
Seasonality Move:
-16.46%
Sell
31
FATE
Fate Therapeutics
Last Price:
4.05
Seasonality Move:
0.14%
Buy
53
Palisade Bio (PALI)
is a Buy
Is Palisade Bio a Buy, Sell or Hold?
- The current Palisade Bio [PALI] share price is $7.74. The Score for PALI is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- PALI is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
31
Fate Therapeutics (FATE)
is a Sell
Is Fate Therapeutics a Buy, Sell or Hold?
- The current Fate Therapeutics [FATE] share price is $4.06. The Score for FATE is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
- FATE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PALI Stock Price Chart
What is Palisade Bio's stock price today?
-
The Palisade Bio share price today is $7.74
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PALI is experiencing buying pressure, which is a positive indicator for future bullish movement.
FATE Stock Price Chart
What is Fate Therapeutics's stock price today?
-
The Fate Therapeutics share price today is $4.06
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FATE is experiencing selling pressure, which indicates risk of future bearish movement.
PALI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.37 | Buy |
Relative Strength Index (14 RSI): | 65.14 | Buy |
Chaikin Money Flow: | 106681 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.89 - 6.65) | Buy |
Bollinger Bands (100): | (5.41 - 8.49) | Buy |
FATE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.72 | Sell |
Relative Strength Index (14 RSI): | 27.25 | Sell |
Chaikin Money Flow: | -1914814 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.19 - 6.53) | Sell |
Bollinger Bands (100): | (3.98 - 7.14) | Sell |
PALI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 6.61 | Buy |
20-day SMA: | 5.78 | Buy |
50-day SMA: | 5.79 | Buy |
200-day SMA: | 9.65 | Sell |
8-day EMA: | 6.7 | Buy |
20-day EMA: | 6.14 | Buy |
50-day EMA: | 6.16 | Buy |
200-day EMA: | 23.89 | Sell |
FATE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 4.03 | Buy |
20-day SMA: | 4.96 | Sell |
50-day SMA: | 6.35 | Sell |
200-day SMA: | 4.06 | Buy |
8-day EMA: | 4.19 | Sell |
20-day EMA: | 4.86 | Sell |
50-day EMA: | 5.58 | Sell |
200-day EMA: | 5.69 | Sell |
Palisade Bio Earnings Growth & PALI Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.55 per share, a decrease next quarter of $0.00 per share, an increase this year of $13.73 per share, and an increase next year of $3.45 per share.
Fate Therapeutics Earnings Growth & FATE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.07 per share, an increase next quarter of $0.05 per share, a decrease this year of $0.15 per share, and an increase next year of $0.20 per share.
Palisade Bio Technical Analysis
Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Fate Therapeutics Technical Analysis
Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |